Does TREPROSTINIL Cause Disease progression? 601 Reports in FDA Database
Boost Your Natural Energy & Metabolism
Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.
According to the FDA Adverse Event Reporting System (FAERS), 601 reports of Disease progression have been filed in association with TREPROSTINIL (TYVASO). This represents 0.7% of all adverse event reports for TREPROSTINIL.
601
Reports of Disease progression with TREPROSTINIL
0.7%
of all TREPROSTINIL reports
279
Deaths
290
Hospitalizations
How Dangerous Is Disease progression From TREPROSTINIL?
Of the 601 reports, 279 (46.4%) resulted in death, 290 (48.3%) required hospitalization, and 33 (5.5%) were considered life-threatening.
Is Disease progression Listed in the Official Label?
This adverse event is not currently listed in the official FDA drug label for TREPROSTINIL. However, 601 reports have been filed with the FAERS database.
What Other Side Effects Does TREPROSTINIL Cause?
Dyspnoea (16,348)
Headache (14,051)
Diarrhoea (11,335)
Nausea (10,320)
Cough (8,945)
Fatigue (7,440)
Dizziness (7,405)
Infusion site pain (5,169)
Vomiting (5,097)
Death (4,764)
What Other Drugs Cause Disease progression?
RITUXIMAB (7,282)
CYCLOPHOSPHAMIDE (7,100)
DOXORUBICIN (6,165)
VINCRISTINE (5,252)
PREDNISONE (5,096)
BEVACIZUMAB (4,653)
DEXAMETHASONE (4,545)
CARBOPLATIN (4,538)
CAPECITABINE (3,808)
ETOPOSIDE (3,776)
Which TREPROSTINIL Alternatives Have Lower Disease progression Risk?
TREPROSTINIL vs TREPROSTINIL DIOLAMINE
TREPROSTINIL vs TRETINOIN
TREPROSTINIL vs TRIAMCINOLONE
TREPROSTINIL vs TRIAMCINOLONE ACETONIDE
TREPROSTINIL vs TRIAMCINOLONE HEXACETONIDE